Pfizer Sells $700M Stake in Haleon, Trimming Ownership to 7.3%
8 hours ago · Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...
Pfizer to sell $3 billion stake in Sensodyne maker Haleon - MSN
The sale of 700 million Haleon shares at 357 pence apiece is a discount of about 2.8% to the stock's closing price on Tuesday. ... Pfizer, which will remain Haleon's largest shareholder after the ...
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
1 day ago · Pfizer PFE-0.72%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN-0.03%decrease; red down pointing triangle for 2.50 billion ...
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale - Yahoo …
2 days ago · Pfizer sold shares of Haleon last year, including a £2.4 billion overnight sale in the autumn. Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units.
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale (2)
2 days ago · Pfizer Inc. sold about 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne toothpaste. The deal raised around £2.5 billion ($3.1 billion) for the seller, which offered the shares through an accelerated placement with investors, according to terms seen by Bloomberg.
Pfizer to sell 700M ordinary shares of Haleon - Markets Insider
2 days ago · Completion of the Offering is expected to reduce Pfizer’s interest in Haleon from approximately 15.0% to approximately 7.3% of Haleon’s issued ordinary shares with voting rights.
Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says …
2 days ago · Pfizer is looking to sell about 700 million ordinary shares in Haleon , its bookrunner J.P. Morgan said on Tuesday, lowering its stake in the British consumer healthcare company to about 7.3% from ...
Pfizer Provides Update on Ownership Interest in Haleon
Jun 1, 2022 · However, in keeping with Pfizer’s transformation into a more focused, global leader in science-based innovative medicines and vaccines, the company intends to exit its 32% ownership interest in Haleon in a disciplined manner, with the objective of maximizing value for Pfizer shareholders.
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Sep 30, 2024 · Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil...
Drug Giant Pfizer Sells $3.3 Billion Stake in Sensodyne-Maker Haleon
Sep 30, 2024 · (Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and...
- Some results have been removed